drugset / Trial / NCT02784054

Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor

NCT02784054

Phase 2 Unknown 25 enrolled Samsung Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the outcome of intracranial non-germinomatous germ cell tumor (NGGCT) treated with reduced radiotherapy following high dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT).

Timeline

Start
2014-04
Primary completion
2021-03
Completion
2023-03

Drugs

EvaluationDrugModalityDoseRoute
Background Bleomycin Unknown
Background Carboplatin Small molecule
Background Cyclophosphamide Other / unclassified
Background Etoposide Small molecule
Background Melphalan Small molecule
Background Thiotepa Other / unclassified